Цитирование: | 1. Ebert AD, J Yu, FF Rose, Jr., VB Mattis, CL Lorson, JA Thomson and CN Svendsen. (2009). Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457:277-280.
2. Medvedev SP, EV Grigor'eva, AI Shevchenko, AA Malakhova, EV Dementyeva, AA Shilov, EA Pokushalov, AM Zaidman, MA Aleksandrova, et al. (2011). Human induced pluripotent stem cells derived from fetal neural stem cells successfully undergo directed differentiation into cartilage. Stem Cells Dev 20:1099-1112.
3. Moretti A, M Bellin, A Welling, CB Jung, JT Lam, L Bott-Flugel, T Dorn, A Goedel, C Hohnke, et al. (2010). Patientspecific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 363:1397-1409.
4. Jacob HJ and AE Kwitek. (2002). Rat genetics: attaching physiology and pharmacology to the genome. Nat Rev Genet 3:33-42.
5. Buehr M, S Meek, K Blair, J Yang, J Ure, J Silva, R McLay, J Hall, QL Ying and A Smith. (2008). Capture of authentic embryonic stem cells from rat blastocysts. Cell 135:1287-1298.
6. Li P, C Tong, R Mehrian-Shai, L Jia, N Wu, Y Yan, RE Maxson, EN Schulze, H Song, et al. (2008). Germline competent embryonic stem cells derived from rat blastocysts. Cell 135:1299-1310.
7. Mak W, TB Nesterova, M de Napoles, R Appanah, S Yamanaka, AP Otte and N Brockdorff. (2004). Reactivation of the paternal X chromosome in early mouse embryos. Science 303:666-669.
8. Okamoto I, AP Otte, CD Allis, D Reinberg and E Heard. (2004). Epigenetic dynamics of imprinted X inactivation during early mouse development. Science 303:644-649.
9. Stadtfeld M, N Maherali, DT Breault and K Hochedlinger. (2008). Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2:230-240.
10. Papp B and K Plath. (2013). Epigenetics of reprogramming to induced pluripotency. Cell 152:1324-1343.
11. Minkovsky A, S Patel and K Plath. (2012). Concise review: pluripotency and the transcriptional inactivation of the female mammalian X chromosome. Stem Cells 30:48-54.
12. Carey BW, S Markoulaki, J Hanna, K Saha, Q Gao, M Mitalipova and R Jaenisch. (2009). Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci USA 106:157-162.
13. Dull T, R Zufferey, M Kelly, RJ Mandel, M Nguyen, D Trono and L Naldini. (1998). A third-generation lentivirus vector with a conditional packaging system. J Virol 72: 8463-8471.
14. Cao L, JD Gibson, S Miyamoto, V Sail, R Verma, DW Rosenberg, CE Nelson and C Giardina. (2011). Intestinal lineage commitment of embryonic stem cells. Differentiation 81:1-10.
15. Shevchenko AI, SV Pavlova, EV Dementyeva and SM Zakian. (2009). Mosaic heterochromatin of the inactive X chromosome in vole Microtus rossiaemeridionalis. Mamm Genome 20:644-653.
16. Vaskova EA, EV Dementyeva, AI Shevchenko, SV Pavlova, EV Grigor'eva, AI Zhelezova, JL Vandeberg and SM Zakian. (2014). Dynamics of the two heterochromatin types during imprinted X chromosome inactivation in vole Microtus levis. PLoS One 9:e88256.
17. Kim JB, B Greber, MJ Arauzo-Bravo, J Meyer, KI Park, H Zaehres and HR Scholer. (2009). Direct reprogramming of human neural stem cells by OCT4. Nature 461:649-3.
18. Kumaki Y, M Oda and M Okano. (2008). QUMA: quantification tool for methylation analysis. Nucleic Acids Res 36:W170-W175.
19. Liskovykh M, I Chuykin, A Ranjan, D Safina, E Popova, E Tolkunova, V Mosienko, JM Minina, NS Zhdanova, et al. (2011). Derivation, characterization, and stable transfection of induced pluripotent stem cells from Fischer344 rats. PLoS One 6:e27345.
20. Hogan B, 2ed. (1994). Manipulating the Mouse Embryo. Cold Spring Harbor Laboratory Press, NY.
21. Fujiwara TM and DG Bichet. (2005). Molecular biology of hereditary diabetes insipidus. JAmSoc Nephrol 16:2836-2846.
22. Schmale H and D Richter. (1984). Single base deletion in the vasopressin gene is the cause of diabetes insipidus in Brattleboro rats. Nature 308:705-709.
23. Valtin H, WH Sawyer and HW Sokol. (1965). Neurohypophysial principles in rats homozygous and heterozygous for hypothalamic diabetes insipidus (Brattleboro strain). Endocrinology 77:701-706.
24. Laurent LC, I Ulitsky, I Slavin, H Tran, A Schork, R Morey, C Lynch, JV Harness, S Lee, et al. (2011). Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8:106-118.
25. Sugawara A, K Goto, Y Sotomaru, T Sofuni and T Ito. (2006). Current status of chromosomal abnormalities in mouse embryonic stem cell lines used in Japan. Comp Med 56:31-34.
26. Pasque V, J Tchieu, R Karnik, M Uyeda, A Sadhu Dimashkje, D Case, B Papp, G Bonora, S Patel, et al. (2014). X chromosome reactivation dynamics reveal stages of reprogramming to pluripotency. Cell 159:1681-1697.
27. Trapnell C, L Pachter and SL Salzberg. (2009). TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105-1111.
28. Anders S and W Huber. (2010). Differential expression analysis for sequence count data. Genome Biol 11:R106.
29. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
30. Marks H and HG Stunnenberg. (2013). Transcription regulation and chromatin structure in the pluripotent ground state. Biochim Biophys Acta 1839:129-137.
31. Nichols J and A Smith. (2009). Naive and primed pluripotent states. Cell Stem Cell 4:487-492.
32. Tesar PJ, JG Chenoweth, FA Brook, TJ Davies, EP Evans, DL Mack, RL Gardner and RD McKay. (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448:196-199.
33. Hong J, H He, P Bui, B Ryba-White, MAK Rumi, MJ Soares, D Dutta, S Paul, M Kawamata, et al. (2013). A focused microarray for screening rat embryonic stem cell lines. Stem Cell Dev 22:431-443.
34. Chen Y, K Blair and A Smith. (2013). Robust self-renewal of rat embryonic stem cells requires fine-tuning of glycogen synthase kinase-3 inhibition. Stem Cell Reports 1:209-217.
35. Meek S, J Wei, L Sutherland, B Nilges, M Buehr, SR Tomlinson, AJ Thomson and T Burdon. (2013). Tuning of beta-catenin activity is required to stabilize self-renewal of rat embryonic stem cells. Stem Cells 31:2104-2115.
36. Strumpf D, CA Mao, Y Yamanaka, A Ralston, K Chawengsaksophak, F Beck and J Rossant. (2005). Cdx2 is required for correct cell fate specification and differentiation of trophectoderm in the mouse blastocyst. Development 132:2093-2102.
37. Latos PA and M Hemberger. (2013). Review: the transcriptional and signalling networks of mouse trophoblast stem cells. Placenta 35 Suppl:S81-S5.
38. Chaumeil J, I Okamoto, M Guggiari and E Heard. (2002). Integrated kinetics of X chromosome inactivation in differentiating embryonic stem cells. Cytogenet Genome Res 99:75-84.
39. Chadwick BP and HF Willard. (2004). Multiple spatially distinct types of facultative heterochromatin on the human inactive X chromosome. Proc Natl Acad Sci USA 101:17450-17455.
40. Coppola G, A Pinton, EM Joudrey, PK Basrur and WA King. (2008). Spatial distribution of histone isoforms on the bovine active and inactive X chromosomes. Sex Dev 2:12-23.
41. Zakharova IS, AI Shevchenko, AG Shilov, TB Nesterova, JL Vandeberg and SM Zakian. (2011). Histone H3 trimethylation at lysine 9 marks the inactive metaphase X chromosome in the marsupial Monodelphis domestica. Chromosoma 120:177-183.
42. Medvedev SP, AI Shevchenko and SM Zakian. (2010). Induced pluripotent stem cells: problems and advantages when applying them in regenerative medicine. Acta Naturae 2:18-28.
43. Blij S, A Parenti, N Tabatabai-Yazdi and A Ralston. (2015). Cdx2 efficiently induces trophoblast stem-like cells in näve, but not primed, pluripotent stem cells. Stem Cell Dev 24:1352-1365.
44. Orkin SH and K Hochedlinger. (2011). Chromatin connections to pluripotency and cellular reprogramming. Cell 145:835-850.
45. Bratt-Leal AM, RL Carpenedo and TC McDevitt. (2009). Engineering the embryoid body microenvironment to direct embryonic stem cell differentiation. Biotechnol Prog 25:43-51.
|